Vericel Corp (VCEL)
56.68
-0.58
(-1.01%)
USD |
NASDAQ |
Nov 21, 14:35
Vericel Price: 56.68 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 55.83 | 57.34 | 55.33 | 57.26 | 335278.0 |
Nov 19, 2024 | 52.68 | 56.20 | 52.52 | 55.83 | 346344.0 |
Nov 18, 2024 | 52.25 | 53.78 | 51.53 | 52.89 | 388012.0 |
Nov 15, 2024 | 53.05 | 53.47 | 51.85 | 52.48 | 410586.0 |
Nov 14, 2024 | 55.63 | 55.70 | 52.65 | 52.74 | 415968.0 |
Nov 13, 2024 | 56.11 | 57.05 | 54.70 | 55.47 | 503064.0 |
Nov 12, 2024 | 56.11 | 57.81 | 55.75 | 55.89 | 562377.0 |
Nov 11, 2024 | 54.50 | 57.35 | 54.05 | 56.78 | 596244.0 |
Nov 08, 2024 | 49.54 | 54.47 | 49.54 | 54.00 | 645360.0 |
Nov 07, 2024 | 49.23 | 50.76 | 46.00 | 50.03 | 578177.0 |
Nov 06, 2024 | 47.35 | 48.77 | 46.20 | 48.04 | 806127.0 |
Nov 05, 2024 | 44.32 | 45.66 | 43.81 | 44.75 | 523796.0 |
Nov 04, 2024 | 44.03 | 44.66 | 43.53 | 44.37 | 290629.0 |
Nov 01, 2024 | 44.39 | 45.28 | 43.60 | 43.99 | 299660.0 |
Oct 31, 2024 | 45.54 | 45.60 | 43.60 | 44.04 | 254450.0 |
Oct 30, 2024 | 45.52 | 46.56 | 44.95 | 45.54 | 323861.0 |
Oct 29, 2024 | 45.30 | 45.89 | 44.67 | 45.83 | 277843.0 |
Oct 28, 2024 | 44.01 | 45.96 | 43.74 | 45.66 | 392122.0 |
Oct 25, 2024 | 43.11 | 44.49 | 42.76 | 43.75 | 723693.0 |
Oct 24, 2024 | 42.47 | 43.11 | 42.02 | 42.87 | 343497.0 |
Oct 23, 2024 | 41.52 | 42.31 | 41.34 | 42.28 | 323694.0 |
Oct 22, 2024 | 40.89 | 41.95 | 40.52 | 41.83 | 270902.0 |
Oct 21, 2024 | 41.30 | 42.28 | 40.78 | 41.18 | 347310.0 |
Oct 18, 2024 | 40.76 | 41.82 | 40.70 | 41.66 | 250030.0 |
Oct 17, 2024 | 41.26 | 41.26 | 39.75 | 40.67 | 350593.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.25
Minimum
Mar 18 2020
67.81
Maximum
Jun 28 2021
34.38
Average
34.04
Median
Oct 05 2023
Price Benchmarks
Catalyst Pharmaceuticals Inc | 21.03 |
Exelixis Inc | 34.73 |
Halozyme Therapeutics Inc | 45.28 |
ADMA Biologics Inc | 21.33 |
Natera Inc | 169.44 |
Price Related Metrics
PE Ratio | 809.71 |
PS Ratio | 12.10 |
Price to Book Value | 10.87 |
Earnings Yield | 0.12% |
Market Cap | 2.798B |
Normalized PE Ratio | 809.71 |